{
    "clinical_study": {
        "@rank": "89080", 
        "arm_group": [
            {
                "arm_group_label": "Group Naproxen sodium (Group N)", 
                "arm_group_type": "Active Comparator", 
                "description": "Group N received naproxen sodium 550 mg 60 minutes before surgery."
            }, 
            {
                "arm_group_label": "Group Naproxen sodium codeine phosphate (Group NC)", 
                "arm_group_type": "Active Comparator", 
                "description": "Group NC received naproxen sodium 550 mg+30 mg codeine 60 minutes before surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "In this study, the aim is to compare the efficacy of single dose naproxen sodium and\n      combination of naproxen sodium-codeine phosphate on post-operative pain in adult patients\n      undergoing arthroscopic menisectomy.Pre-emptive oral naproxen-codeine may be safely and more\n      advantageous than naproxen alone."
        }, 
        "brief_title": "Naproxen Codeine in Arthroscopic Surgery", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Arthroscopic Meniscus Surgery", 
        "detailed_description": {
            "textblock": "Patients receiving preemptive oral naproxen sodium (Group N) or naproxen sodium-codeine\n      phosphate (Group NC) were assigned in 2 groups.Preoperatively, drugs were given orally by a\n      nurse unaware of the study to both groups within 60 minutes before surgery. Hemodynamic\n      datas, possible side effects, pain and sedation levels of patients were recorded. Patient's\n      pain and sedation levels were statistically assessed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing arthroscopic meniscectomy were included in the study.\n\n        Exclusion Criteria:\n\n          -  \u2264 18 years of age\n\n          -  hypersensitivity to non-steroidal anti-inflammatory drugs and codeine,\n\n          -  history of peptic ulcer, gastritis, upper gastrointestinal bleeding\n\n          -  coagulation disorder\n\n          -  serious hepatic and renal impairment\n\n          -  pregnancy\n\n          -  long-term NSAID and opioid use"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "61", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01952652", 
            "org_study_id": "KA12/268"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group Naproxen sodium (Group N)", 
                "description": "drug will be given 60 minutes before surgery", 
                "intervention_name": "Group N:Naproxen sodium", 
                "intervention_type": "Drug", 
                "other_name": "Apranax fort tb, Abdi Ibrahim Ila\u00e7,Turkiye"
            }, 
            {
                "arm_group_label": "Group Naproxen sodium codeine phosphate (Group NC)", 
                "description": "drug will be given 60 minutes before surgery", 
                "intervention_name": "Group NC :naproxen sodium codeine phosphate", 
                "intervention_type": "Drug", 
                "other_name": "Apranax plus tb, Abdi Ibrahim Ilac, Turkey"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Naproxen", 
                "Codeine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Naproxen-codeine", 
            "preemptive analgesia", 
            "day case surgery"
        ], 
        "lastchanged_date": "September 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Adana", 
                    "country": "Turkey", 
                    "zip": "01250"
                }, 
                "name": "Baskent University School of Medicine Adana Teaching and Research Hospital"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Post-operative Analgesic Effects of Naproxen Sodium and Naproxen Sodium-codeine Phosphate Administered Preemptively for Arthroscopic Meniscus Surgery", 
        "overall_official": {
            "affiliation": "Baskent University School of Medicine", 
            "last_name": "Anis Aribogan, Prof.,MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "patients will be followed postoperatively 18 hours for pain levels", 
            "measure": "Pain scores as measured by Visual Analogue Scale were significantly lower in Group Naproxen codeine (group NC) at all time points compared to Group Naproxen (group N) in 61 patients who underwent arthroscopic meniscus surgery.", 
            "safety_issue": "Yes", 
            "time_frame": "postoperative 18 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01952652"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Baskent University", 
            "investigator_full_name": "CAGLA BALI,MD", 
            "investigator_title": "MD,Anesthesiology and Reanimation", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Baskent University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Baskent University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}